Vertex Pharmaceuticals Inc
XMUN:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
XMUN:VX1
|
US |
|
B
|
Basf Se
SWB:BAS
|
DE |
|
Taiwan Semiconductor Manufacturing Co Ltd
TWSE:2330
|
TW |
|
L
|
Logitech International SA
XHAM:LTEC
|
CH |
|
LVMH Moet Hennessy Louis Vuitton SE
F:MOH
|
FR |
|
A
|
Alaska Air Group Inc
DUS:ALK
|
US |
|
M
|
Matas A/S
F:1MTA
|
DK |
|
Kimberly-Clark de Mexico SAB de CV
F:4FX
|
MX |
|
V
|
Vinci SA
XMUN:SQU
|
FR |
|
Budweiser Brewing Company APAC Ltd
F:4BB1
|
HK |
|
H
|
Halliburton Co
SWB:HAL
|
US |
|
D
|
Dongfang Electric Corp Ltd
F:DEU
|
CN |
|
A
|
Arcosa Inc
F:EOB
|
US |
|
Industria de Diseno Textil SA
F:IXD2
|
ES |
|
W
|
Waste Connections Inc
F:UI51
|
CA |
|
C
|
Cisco Systems Inc
F:CIS
|
US |
|
TechPrecision Corp
NASDAQ:TPCS
|
US |
|
S
|
Sunstone Hotel Investors Inc
SWB:UF2
|
US |
|
Taikisha Ltd
F:75L
|
JP |
|
U
|
Unilever PLC
XMUN:UNVB
|
UK |
|
C
|
Caterpillar Inc
XBER:CAT1
|
US |
Bankruptcy Probability
Vertex Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vertex Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
320.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
69.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
461.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vertex Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vertex Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.
